2024
The early COVID-19 pandemic period and associated gestational weight gain
Madein A, Lundsberg L, Culhane J, Partridge C, Son M, Merriam A. The early COVID-19 pandemic period and associated gestational weight gain. Journal Of Perinatal Medicine 2024, 0 PMID: 39485230, DOI: 10.1515/jpm-2024-0088.Peer-Reviewed Original ResearchGestational weight gainGestational ageWeight gainAssociated with weight gainInstitute of MedicineMaternal weight gainWeight gain riskRetrospective cohort studyInstitute of Medicine recommendationsTertiary care hospitalNo significant differenceEarly pandemic periodCohort studyPrimary outcomeMedical record dataCare hospitalPandemic groupPandemic epochSignificant differenceLogistic regressionElectronic medical record dataExposure groupMultinominal logistic regressionPandemic periodAgeLidocaine patches after cesarean sections: a randomized control trial
Arkfeld C, Starosta A, Esencan E, Athens Z, Lundsberg L, Merriam A. Lidocaine patches after cesarean sections: a randomized control trial. American Journal Of Obstetrics & Gynecology MFM 2024, 6: 101536. PMID: 39491590, DOI: 10.1016/j.ajogmf.2024.101536.Peer-Reviewed Original ResearchPost-operative pain scoresLidocaine patch groupVisual analog scalePost-operative day 1Pain scoresLidocaine patchCesarean sectionAnalog scalePatch groupDay 1Post-cesarean pain managementPost-operative hospital stayVisual analog pain scoreDay 3Day 2Day 4Controlled trialsControlled trials of patientsAnalog pain scoresBaseline maternal characteristicsTrial of patientsOpiate use disorderPain management strategiesPost-operative periodAbdominal hernia repairFor Patients Undergoing an Induction of Labor, Does Increased Body Mass Index Necessitate Higher Doses of Misoprostol? [ID 2683640]
Mason-Otey A, Lundsberg L, Culhane J, Merriam A. For Patients Undergoing an Induction of Labor, Does Increased Body Mass Index Necessitate Higher Doses of Misoprostol? [ID 2683640]. Obstetrics And Gynecology 2024, 143: 46s-46s. DOI: 10.1097/01.aog.0001013576.14925.24.Peer-Reviewed Original ResearchInduction of laborBody mass indexBody mass index categoriesDose of misoprostolMisoprostol doseClass IIIMass indexProlonged induction of laborClass IIAssociated with increased BMIClass IIncreased BMIPre-gestational diabetesClass II obesityClass I obesityRetrospective cohort analysisMisoprostol administrationObese patientsII obesityMisoprostolInvestigate safetyHigh dosesPrimary outcomeCohort analysisPatientsAbsence of adverse maternal and neonatal outcomes in patients with 1 or 2 abnormal values during early glucose tolerance testing
Geng B, Lundsberg L, Culhane J, Merriam A. Absence of adverse maternal and neonatal outcomes in patients with 1 or 2 abnormal values during early glucose tolerance testing. American Journal Of Obstetrics And Gynecology 2024, 230: e103-e107. PMID: 38242338, DOI: 10.1016/j.ajog.2024.01.007.Peer-Reviewed Original Research284 Postpartum diabetes screening rates and 1-year outcomes for individuals with early onset gestational diabetes
Pifer B, Geng B, Lundsberg L, Culhane J, Partridge C, Merriam A. 284 Postpartum diabetes screening rates and 1-year outcomes for individuals with early onset gestational diabetes. American Journal Of Obstetrics And Gynecology 2024, 230: s163-s164. DOI: 10.1016/j.ajog.2023.11.306.Peer-Reviewed Original Research
2023
Collaboration between maternal-fetal medicine and family planning: a survey of Northeast US academic medical centers
Merriam A, Lundsberg L, Cutler A, Maxam T, Paul M. Collaboration between maternal-fetal medicine and family planning: a survey of Northeast US academic medical centers. Journal Of Perinatal Medicine 2023, 52: 81-89. PMID: 37853776, DOI: 10.1515/jpm-2023-0118.Peer-Reviewed Original ResearchConceptsMaternal-fetal medicineAcademic medical centerMedical CenterAbortion carePatient careFamily planningUS academic medical centersPatient care teamOptimal patient careCross-sectional online surveyPractice patternsCare teamResponse rateBivariate analysisPractice locationCareDemographic informationImproved educationAbortion servicesAbortion accessFindings highlight areasOne-thirdLikert scale questionsMedicineHighlight areasLow-Dose Aspirin during Pregnancy and Postpartum Bleeding
White K, Son M, Lundsberg L, Culhane J, Partridge C, Reddy U, Merriam A. Low-Dose Aspirin during Pregnancy and Postpartum Bleeding. American Journal Of Perinatology 2023, 40: 1390-1397. PMID: 37211010, DOI: 10.1055/a-2096-5199.Peer-Reviewed Original ResearchConceptsLow-dose aspirinPostpartum blood lossTiming of discontinuationBlood lossPostpartum bleedingPostpartum hemorrhageLDA useUse of LDARed blood cell transfusionBlood cell transfusionRetrospective cohort studySystemic lupus erythematosusTime of deliveryDiagnosis of diabetesLogistic regression modelingElectronic medical recordsAspirin 81Ideal dosingPreeclampsia preventionCell transfusionDose aspirinCohort studyHypertensive diseaseLupus erythematosusPrimary outcomeSevere Maternal Morbidity Review and Preventability Assessment in a Large Academic Center
Grechukhina O, Lipkind H, Lundsberg L, Merriam A, Raab C, Leon-Martinez D, Campbell K. Severe Maternal Morbidity Review and Preventability Assessment in a Large Academic Center. Obstetrics And Gynecology 2023, 141: 857-860. PMID: 36897178, DOI: 10.1097/aog.0000000000005116.Peer-Reviewed Original ResearchConceptsSevere maternal morbiditySystem-level factorsYale-New Haven HospitalRetrospective cohort studyHealth careDetailed case reviewLarge academic centerSMM ratesMaternal morbidityCohort studyPreventability assessmentPreventable causeSMM casesMorbidity reviewAmerican CollegeAcademic centersConsensus criteriaCase reviewPractice changeCareCauseMorbidityHemorrhagePreventabilityReviewEvaluating the relationship between early glucose tolerance test screening and adverse neonatal and maternal outcomes
Geng B, Lundsberg L, Culhane J, Merriam A. Evaluating the relationship between early glucose tolerance test screening and adverse neonatal and maternal outcomes. American Journal Of Obstetrics And Gynecology 2023, 228: s441-s442. DOI: 10.1016/j.ajog.2022.11.764.Peer-Reviewed Original Research
2022
Placenta accreta spectrum: clinical and sonographic characteristics associated with predictive ability
Greenberg V, Lundsberg L, Kohari K, Merriam A. Placenta accreta spectrum: clinical and sonographic characteristics associated with predictive ability. American Journal Of Obstetrics And Gynecology 2022, 226: s586. DOI: 10.1016/j.ajog.2021.11.968.Peer-Reviewed Original Research
2020
547: Perinatal outcomes in obese women with 1 abnormal value on 3-hour glucose tolerance test
Greenberg V, Lundsberg L, Reddy U, Grobman W, Silver R, Simhan H, Chung J, Haas D, Mercer B, Wapner R, Merriam A. 547: Perinatal outcomes in obese women with 1 abnormal value on 3-hour glucose tolerance test. American Journal Of Obstetrics And Gynecology 2020, 222: s352. DOI: 10.1016/j.ajog.2019.11.563.Peer-Reviewed Original Research